A double negative: Inhibition of hepatic gi signaling improves glucose homeostasis

Research output: Contribution to journalReview article

Abstract

Hepatic glucose production (HGP) is a key determinant of glucose homeostasis. Glucagon binding to its cognate seven-transmembrane Gs-coupled receptor in hepatocytes stimulates cAMP production, resulting in increased HGP. In this issue of the JCI, Rossi and colleagues tested the hypothesis that activation of hepatic Gi–coupled receptors, which should inhibit cAMP production, would oppose the cAMP-inducing action of glucagon and thereby decrease HGP. Surprisingly, however, the opposite occurred: activation of Gi signaling increased HGP via a novel mechanism, while inhibition of Gi signaling reduced HGP. These results define a new physiologic role for hepatic Gi signaling and identify a potential therapeutic target for HGP regulation.

Original languageEnglish (US)
Pages (from-to)567-569
Number of pages3
JournalJournal of Clinical Investigation
Volume128
Issue number2
DOIs
StatePublished - Feb 1 2018

Fingerprint

Homeostasis
Glucose
Liver
Glucagon
Hepatocytes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A double negative : Inhibition of hepatic gi signaling improves glucose homeostasis. / Spiegel, Allen M.

In: Journal of Clinical Investigation, Vol. 128, No. 2, 01.02.2018, p. 567-569.

Research output: Contribution to journalReview article

@article{998e3344a5ae41c882426767f6617507,
title = "A double negative: Inhibition of hepatic gi signaling improves glucose homeostasis",
abstract = "Hepatic glucose production (HGP) is a key determinant of glucose homeostasis. Glucagon binding to its cognate seven-transmembrane Gs-coupled receptor in hepatocytes stimulates cAMP production, resulting in increased HGP. In this issue of the JCI, Rossi and colleagues tested the hypothesis that activation of hepatic Gi–coupled receptors, which should inhibit cAMP production, would oppose the cAMP-inducing action of glucagon and thereby decrease HGP. Surprisingly, however, the opposite occurred: activation of Gi signaling increased HGP via a novel mechanism, while inhibition of Gi signaling reduced HGP. These results define a new physiologic role for hepatic Gi signaling and identify a potential therapeutic target for HGP regulation.",
author = "Spiegel, {Allen M.}",
year = "2018",
month = "2",
day = "1",
doi = "10.1172/JCI99037",
language = "English (US)",
volume = "128",
pages = "567--569",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

TY - JOUR

T1 - A double negative

T2 - Inhibition of hepatic gi signaling improves glucose homeostasis

AU - Spiegel, Allen M.

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Hepatic glucose production (HGP) is a key determinant of glucose homeostasis. Glucagon binding to its cognate seven-transmembrane Gs-coupled receptor in hepatocytes stimulates cAMP production, resulting in increased HGP. In this issue of the JCI, Rossi and colleagues tested the hypothesis that activation of hepatic Gi–coupled receptors, which should inhibit cAMP production, would oppose the cAMP-inducing action of glucagon and thereby decrease HGP. Surprisingly, however, the opposite occurred: activation of Gi signaling increased HGP via a novel mechanism, while inhibition of Gi signaling reduced HGP. These results define a new physiologic role for hepatic Gi signaling and identify a potential therapeutic target for HGP regulation.

AB - Hepatic glucose production (HGP) is a key determinant of glucose homeostasis. Glucagon binding to its cognate seven-transmembrane Gs-coupled receptor in hepatocytes stimulates cAMP production, resulting in increased HGP. In this issue of the JCI, Rossi and colleagues tested the hypothesis that activation of hepatic Gi–coupled receptors, which should inhibit cAMP production, would oppose the cAMP-inducing action of glucagon and thereby decrease HGP. Surprisingly, however, the opposite occurred: activation of Gi signaling increased HGP via a novel mechanism, while inhibition of Gi signaling reduced HGP. These results define a new physiologic role for hepatic Gi signaling and identify a potential therapeutic target for HGP regulation.

UR - http://www.scopus.com/inward/record.url?scp=85041464617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041464617&partnerID=8YFLogxK

U2 - 10.1172/JCI99037

DO - 10.1172/JCI99037

M3 - Review article

VL - 128

SP - 567

EP - 569

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 2

ER -